Wei Cui

2.5k total citations
86 papers, 1.8k citations indexed

About

Wei Cui is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Wei Cui has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 30 papers in Oncology and 24 papers in Hematology. Recurrent topics in Wei Cui's work include Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Wei Cui is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Wei Cui collaborates with scholars based in United States, China and United Kingdom. Wei Cui's co-authors include Diane L. Persons, Jill C. Pelling, Eugenia M. Yazlovitskaya, Bryan L. Copple, James P. Luyendyk, Chunfu Wu, Hartmut Jaeschke, Benjamin L. Woolbright, Jessica A. Williams and Wen-Xing Ding and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wei Cui

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Cui United States 22 939 519 364 356 224 86 1.8k
Cheng Ean Chee Singapore 18 955 1.0× 465 0.9× 788 2.2× 302 0.8× 144 0.6× 73 1.9k
Yongdong Feng China 26 972 1.0× 641 1.2× 143 0.4× 397 1.1× 139 0.6× 64 1.7k
Yanping Xu China 22 1.7k 1.8× 587 1.1× 518 1.4× 552 1.6× 114 0.5× 46 2.7k
Lijun Di China 25 1.0k 1.1× 602 1.2× 163 0.4× 389 1.1× 104 0.5× 102 1.9k
Eliana Abdelhay Brazil 26 1.1k 1.2× 474 0.9× 118 0.3× 452 1.3× 204 0.9× 125 2.0k
Wen Zhou China 22 990 1.1× 361 0.7× 139 0.4× 348 1.0× 239 1.1× 67 1.5k
Noel A. Warfel United States 21 1.0k 1.1× 557 1.1× 169 0.5× 375 1.1× 79 0.4× 39 1.7k
Kouhei Yamamoto Japan 24 974 1.0× 425 0.8× 110 0.3× 308 0.9× 221 1.0× 107 1.8k
Zhao‐Yang Lu China 23 779 0.8× 439 0.8× 164 0.5× 387 1.1× 250 1.1× 64 1.7k
Douglas C. Marchion United States 23 1.8k 1.9× 609 1.2× 143 0.4× 253 0.7× 137 0.6× 66 2.3k

Countries citing papers authored by Wei Cui

Since Specialization
Citations

This map shows the geographic impact of Wei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cui more than expected).

Fields of papers citing papers by Wei Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cui. The network helps show where Wei Cui may publish in the future.

Co-authorship network of co-authors of Wei Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Cui. A scholar is included among the top collaborators of Wei Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Cui. Wei Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Xin, Chunjiao Lu, Pei Liu, et al.. (2025). Par6/SOX2 interact to modulate stemness maintenance in glioma by regulating the EGFR/PI3K/AKT signaling cascade. Oncogene. 44(46). 4441–4461. 1 indexed citations
2.
3.
Wang, Hao, Xiao Tong, Hao Zhuang, et al.. (2025). STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinoma. Cell Reports. 44(10). 116429–116429.
4.
Shi, Xiaoling, Chunjiao Lu, Xuewei Wu, et al.. (2024). Acute indomethacin exposure impairs cardiac development by affecting cardiac muscle contraction and inducing myocardial apoptosis in zebrafish (Danio rerio). Ecotoxicology and Environmental Safety. 283. 116976–116976. 3 indexed citations
5.
Rossum, Huub H. van, Stefan Holdenrieder, Bart E.P.B. Ballieux, et al.. (2024). Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study. Clinical Chemistry. 70(4). 669–679. 6 indexed citations
6.
Yang, Cheng, Jie Zhang, Yuchen Han, et al.. (2024). EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non–small cell lung cancer. Proceedings of the National Academy of Sciences. 121(23). e2317790121–e2317790121. 11 indexed citations
7.
Galbo, Phillip M., Wei Yao, Wei Cui, et al.. (2024). TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors. Science Advances. 10(19). eadk1857–eadk1857. 8 indexed citations
8.
Meng, Yangyang, Yidong Wang, Shaopeng Zhang, et al.. (2023). Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy. Journal of Medicinal Chemistry. 66(17). 11815–11830. 6 indexed citations
9.
Ji, Yuan, Jun Wang, Qi Shen, et al.. (2022). Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature. Modern Pathology. 35(7). 865–874. 7 indexed citations
10.
Mohebnasab, Maedeh, Wei Xie, Philipp W. Raess, et al.. (2022). Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling. Blood Advances. 7(1). 40–45. 4 indexed citations
11.
Li, Peng, Margaret S. Williams, Thomas A. White, et al.. (2022). The genetic landscape of germlineDDX41variants predisposing to myeloid neoplasms. Blood. 140(7). 716–755. 43 indexed citations
12.
Kuravi, Sudhakiranmayi, Muhammad Umair Mushtaq, Irfan Saadi, et al.. (2022). Functional characterization of NPM1–TYK2 fusion oncogene. npj Precision Oncology. 6(1). 3–3. 4 indexed citations
13.
Abdallah, Al‐Ola, Ghulam Rehman Mohyuddin, Nausheen Ahmed, et al.. (2021). Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease. SHILAP Revista de lepidopterología. 2(4). 757–764. 4 indexed citations
14.
Li, Peng, Thomas A. White, Wei Xie, et al.. (2021). AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome. Leukemia. 36(3). 664–674. 36 indexed citations
15.
Li, Hong, Jingyu Wang, Chunfu Wu, et al.. (2020). The combination of disulfiram and copper for cancer treatment. Drug Discovery Today. 25(6). 1099–1108. 139 indexed citations
16.
Chen, Xiuxu, et al.. (2020). Increased immature T-cells detected by flow cytometry in post chemotherapeutic patients with acute myeloid leukemia, a case report and small series study.. PubMed Central. 10(6). 351–354. 1 indexed citations
17.
Yin, C. Cameron, Wei Cui, Nianyi Li, et al.. (2019). p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(7). e385–e392. 7 indexed citations
18.
Zhang, Yanhui, Baocun Sun, Xiulan Zhao, et al.. (2016). Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells. Journal of Experimental & Clinical Cancer Research. 35(1). 163–163. 8 indexed citations
19.
Xu, Chuan, Dan Xie, Shi‐Cang Yu, et al.. (2013). β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma. Cancer Research. 73(10). 3181–3189. 79 indexed citations
20.
Kassel, Karen M., Bradley P. Sullivan, Wei Cui, Bryan L. Copple, & James P. Luyendyk. (2012). Therapeutic Administration of the Direct Thrombin Inhibitor Argatroban Reduces Hepatic Inflammation in Mice with Established Fatty Liver Disease. American Journal Of Pathology. 181(4). 1287–1295. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng Ean Chee Breakdown of academic impact, for papers by Yongdong Feng Breakdown of academic impact, for papers by Yanping Xu Breakdown of academic impact, for papers by Lijun Di Breakdown of academic impact, for papers by Eliana Abdelhay Breakdown of academic impact, for papers by Wen Zhou Breakdown of academic impact, for papers by Noel A. Warfel Breakdown of academic impact, for papers by Kouhei Yamamoto Breakdown of academic impact, for papers by Zhao‐Yang Lu Breakdown of academic impact, for papers by Douglas C. Marchion
Rankless by CCL
2026